Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph H Neale

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Neurobiology of Learning and Memory|January 11, 2019
A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognitionJoseph H Neale, Rafal Olszewski
Progress in Neurobiology|November 16, 2019
N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applicationsJoseph H Neale, Tatsuo Yamamoto
Molecular Pain|September 24, 2010
Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain modelMary O Adedoyin, Stefano Vicini, Joseph H Neale
Molecular Pain|August 5, 2008
Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory painTatsuo Yamamoto, Alan Kozikowski, Jia Zhou, et al.
Neurochemistry International|December 1, 2010
Type 2 metabotropic glutamate receptor (mGluR2) fails to negatively couple to cGMP in stably transfected cellsBarbara Wroblewska, Iga N Wegorzewska, Tomasz Bzdega, et al.
Nature Reviews. Drug Discovery|December 13, 2005
NAAG peptidase inhibitors and their potential for diagnosis and therapyJia Zhou, Joseph H Neale, Martin G Pomper, et al.
Psychopharmacology|February 18, 2011
Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophreniaCaterina P Profaci, Kristyn A Krolikowski, Rafal T Olszewski, et al.
Journal of Neurochemistry|January 19, 2006
Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytesBarbara Wroblewska, Iga N Wegorzewska, Tomasz Bzdega, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|September 9, 2006
Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer painOsamu Saito, Tomohiko Aoe, Alan Kozikowski, et al.
The Journal of Biological Chemistry|May 10, 2012
Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophreniaDaiying Zuo, Tomasz Bzdega, Rafal T Olszewski, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Neurobiology of Learning and Memory|January 11, 2019
A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognitionJoseph H Neale, Rafal Olszewski
Progress in Neurobiology|November 16, 2019
N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applicationsJoseph H Neale, Tatsuo Yamamoto
Molecular Pain|September 24, 2010
Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain modelMary O Adedoyin, Stefano Vicini, Joseph H Neale
Molecular Pain|August 5, 2008
Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory painTatsuo Yamamoto, Alan Kozikowski, Jia Zhou, et al.
Neurochemistry International|December 1, 2010
Type 2 metabotropic glutamate receptor (mGluR2) fails to negatively couple to cGMP in stably transfected cellsBarbara Wroblewska, Iga N Wegorzewska, Tomasz Bzdega, et al.
Nature Reviews. Drug Discovery|December 13, 2005
NAAG peptidase inhibitors and their potential for diagnosis and therapyJia Zhou, Joseph H Neale, Martin G Pomper, et al.
Psychopharmacology|February 18, 2011
Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophreniaCaterina P Profaci, Kristyn A Krolikowski, Rafal T Olszewski, et al.
Journal of Neurochemistry|January 19, 2006
Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytesBarbara Wroblewska, Iga N Wegorzewska, Tomasz Bzdega, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|September 9, 2006
Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer painOsamu Saito, Tomohiko Aoe, Alan Kozikowski, et al.
The Journal of Biological Chemistry|May 10, 2012
Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophreniaDaiying Zuo, Tomasz Bzdega, Rafal T Olszewski, et al.
Pageof 4